CIDRZ researcher Professor Groesbeck Parham will lead the Zambian ‘EPIC’ biomarker study searching for a biomarker of persistent high-risk Human Papilloma Virus (HPV) infection as part of a grant to the African Collaborative Center for Microbiome and Genomics Research. The U.S. National Institutes of Health (NIH) recently announced the 4-year grant award of $4.16 million to support the work of the Institute of Human Virology in Nigeria, and CIDRZ, to better understand the epidemiology of HPV infection and cervical cancer. “Cancer of the cervix is the most common cancer in Africa. This grant will address a high-impact public health challenge that affects women’s health in Africa and the rest of the world,” NIH said.
The African Collaborative Center for Microbiome and Genomics Research (ACCME) is a multi-country, multi-institutional collaborative research group involving the Institutes of Human Virology Nigeria and CIDRZ in partnership with international organizations, including Institutes of Genome Sciences and Human Virology, Cambridge University, UK; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA; and the Center for Genomics and Global Health, National Human Genome Research Institute, Bethesda, Maryland, USA.